NCT01332383已完成不适用
Special Drug Use Investigation for AMERGE Tablet (Long-term)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
- 主要终点
- The number of adverse drug reactions and serious adverse events
研究概览
简要总结
To investigate the long-term safety and efficacy of AMERGE (naratriptan hydrochloride) on Japanese patients with migraine headache in clinical setting
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Must use AMERGE for the first time
排除标准
- •Patients with hypersensitivity to naratriptan or any of the components.
- •Patients with history, symptoms, or signs of myocardial infarction, ischemic cardiac or angina inversa
- •Patients with history of cerebral vascular disturbance or transient ischaemic attack
- •Patients with peripheral vascular syndromes
- •Patients with uncontrolled hypertension
- •Patients with severe renal or hepatic impairment
- •Patients using treatment with another 5-HT1 agonist, an ergotamine-containing or ergot-type medication
研究组 & 干预措施
Patients prescribed AMERGE
Patients with migraine disorders prescribed AMERGE during study period
干预措施: Naratriptan (Drug)
结局指标
主要结局
The number of adverse drug reactions and serious adverse events
时间窗: 6 months
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mgCancerNCT01376115Novartis Pharmaceuticals343
招募中
不适用
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung CancerNon-small Cell Lung Cancer (NSCLC)NCT05100069Takeda500
已完成
3 期
Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)Type 2 Diabetes MellitusNCT01697592Merck Sharp & Dohme LLC585
已完成
2 期
A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic NeuralgiaPainDiabetic NeuropathiesNeuralgiaPostherpetic NeuralgiaNCT01124617Janssen Pharmaceutical K.K.91
已完成
3 期
Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In JapanMigraine DisordersNCT00356603GlaxoSmithKline75
